Syrinix has announced the appointment of Dr Ian Buckley-Golder as Non-Executive Chairman of the company.
A physicist by background, Dr Buckley-Golder has considerable experience of growing advanced, technology-based businesses internationally including into the USA, EU and Japan, in a range of market sectors, including electronics, semiconductors, sensors, medical technology and biotechnology. Alongside that, he has specific expertise in terms of Board Governance and the utilisation of intellectual property-based companies, whether Main List, AIM or Venture Capital funded. Dr Buckley-Golder is currently also Chairman of Pettra and Cascade Fund Management and a non-executive director at Oxsensis, the Rainbow Seed Fund and Warwick Ventures.
James Dunning, CEO, commented: "I am delighted to have Ian on board with his considerable experience of technology enterprises and their transformation out of early stage to realising their potential. I very much look forward to working with him as we take Syrinix forward."
Dr Buckley-Golder said: "I am hugely excited about my appointment as Chairman. Syrinix is a company poised on the brink of great success as a lead player in pipeline monitoring solutions. I look forward to working with James and the rest of the Syrinix team as we build upon the company’s significant success to date".
James Dunning also added his thanks to former Chairman John Polden for the critical role he has played in chairing the company since 2009. John Polden will continue to be involved with Syrinix as a non-executive director.